Comments on: Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial

Comments on: Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial https://ibima.eu/en/efficacy-and-safety-of-early-treatment-with-sarilumab-in-hospitalised-adults-with-covid-19-presenting-cytokine-release-syndrome-saricor-study-protocol-of-a-phase-ii-open-label-randomised-multice/ Wed, 01 Jan 2020 00:00:00 +0000 hourly 1 https://wordpress.org/?v=6.5.5